Osteoma secondary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 1: | Line 1: | ||
{{Osteoma}} | |||
{{CMG}}{{AE}}{{MV}} | |||
==Overview== | |||
| Line 6: | Line 10: | ||
==References== | ==References== | ||
{{reflist|1}} | |||
Revision as of 17:41, 20 January 2016
|
Osteoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Osteoma secondary prevention On the Web |
|
American Roentgen Ray Society Images of Osteoma secondary prevention |
|
Risk calculators and risk factors for Osteoma secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]
Overview
Secondary Prevention
Secondary prevention for osteoma includes screening for multiple osteomas among patients with family history or/and a confirmed diagnosis of Gardner syndrome. Thyroid exam and annual ultrasound, should be performed starting at age 10 to 12 years.[1]
References
- ↑ Septer S, Slowik V, Morgan R, Dai H, Attard T (2013). "Thyroid cancer complicating familial adenomatous polyposis: mutation spectrum of at-risk individuals". Hered Cancer Clin Pract. 11 (1): 13. doi:10.1186/1897-4287-11-13. PMC 3854022. PMID 24093640.